Homology Medicines, Inc.
Homology Medicines, Inc. (FIXX) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 179 transactions totaling $161.7M, demonstrating a bearish sentiment with -$57.7M in net insider flow. The most recent transaction on Mar 25, 2024 involved a transaction of 6,448 shares valued at $0.
FIXX Insider Activity Summary
Who Is Buying FIXX Stock?
No significant insider buying has been recorded for FIXX in the recent period.
Who Is Selling FIXX Stock?
No significant insider selling has been recorded for FIXX in the recent period.
Is Homology Medicines, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FIXX is bearish with an Insider Alignment Score of 32/100 and a net flow of -$57.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
FIXX Frequently Asked Questions
Understanding FIXX Insider Activity
Insider trading at Homology Medicines, Inc. (FIXX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading FIXX stock, having executed 179 transactions in the past 90 days. The most active insider is Kush Parmar (Executive), who has made 16 transactions totaling $37.4M.
Related Tools
Track Homology Medicines, Inc. Insider Activity
Get notified when executives and directors at FIXX file new Form 4 transactions